Contrasting disease and nondisease protein aggregation by molecular simulation

Accounts of Chemical Research

Volumn 41, Issue 8, 2008, Pages 1037-1047

  Fawzi, Nicolas Lux ^a   Yap, Eng Hui ^a   Okabe, Yuka ^b   Kohlstedt, Kevin L ^c   Brown, Scott P ^d   Head Gordon, Teresa ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Berkeley   (United States)

^c Northwestern University   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; GENETICS; HUMAN; METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MODELS, MOLECULAR; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING;

EID: 51649109850     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar800062k     Document Type: Article

References (47)

1. Dobson, C. M. Protein folding and misfolding. Nature 2003, 426, 884-890.
2. Goedert, M.; Spillantini, M. G. A century of Alzheimer's disease. Science 2006, 314, 777-781.
3. Cellmer, T.; Douma, R.; Huebner, A.; Prausnitz, J.; Blanch, H. Kinetic studies of protein L aggregation and disaggregation. Biophys. Chem. 2007, 125, 350-359.
4. Clark, E. D. Protein refolding for industrial processes. Curr. Opin. Biotechnol. 2001, 12, 202-207.
5. Tycko, R.; Petkova, A.; Oyler, N.; Chan, C. C.; Balbach, J. Probing the molecular structure of amyloid fibrils with solid-state NMR. Biophys. J. 2002, 82, 187A.
6. King, J.; Haasepettingell, C.; Robinson, A. S.; Speed, M.; Mitraki, A. Thermolabile folding intermediates-inclusion body precursors and chaperonin substrates. FASEB J. 1996, 10, 57-66.
7. Uversky, V. N.; Li, J.; Fink, A. L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 2001, 276, 10737-10744.
8. Silow, M.; Tan, Y. J.; Fersht, A. R.; Oliveberg, M. Formation of short-lived protein aggregates directly from the coil in two-state folding. Biochemistry 1999, 38, 13006-13012.
9. Chiti, F.; Taddei, N.; Baroni, F.; Capanni, C.; Stefani, M.; Ramponi, G.; Dobson, C. M. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 2002, 9, 137-143.
10. Kim, D. E.; Fisher, C.; Baker, D. A breakdown of symmetry in the folding transition state of protein L. J. Mol. Biol. 2000, 298, 971-984.
11. Park, S. H.; Shastry, M. C. R.; Roder, H. Folding dynamics of the B1-domain of protein G explored by ultrarapid mixing. Nat. Struct. Biol. 1999, 6, 943-947.
12. Fawzi, N. L.; Chubukov, V.; Clark, L. A.; Brown, S.; Head-Gordon, T. Influence of denatured and intermediate states of folding on protein aggregation. Protein Sci. 2005, 14, 993-1003.
13. Head-Gordon, T.; Brown, S. Minimalist models for protein folding and design. Curr. Opin. Struct. Biol. 2003, 13, 160-167.
14. Brown, S.; Fawzi, N.; Head-Gordon, T. Coarse-grained sequences for protein folding and design. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 10712-10717.
15. Yap, E. H.; Fawzi, N. L.; Head-Gordon, T. A coarse-grained alpha-carbon protein model with anisotropic hydrogen-bonding. Proteins 2008, 70, 626-638.
16. Thirumalai, D.; Klimov, D. K. Deciphering the timescales and mechanisms of protein folding using minimal off-lattice models. Curr. Opin. Struct. Biol. 1999, 9, 197-207.
17. Wikstrom, M.; Drakenberg, T.; Forsen, S.; Sjobring, U.; Bjorck, L. Three-dimensional solution structure of an immunoglobulin light chain-binding domain of protein-L. Comparison with the IgG-binding domains of protein G. Biochemistry 1994, 33, 14011-14017.
18. Gronenborn, A. M.; Filpula, D. R.; Essig, N. Z.; Achari, A.; Whitlow, M.; Wingfield, P. T.; Clore, G. M. A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein-G. Science 1991, 253, 657-661.
19. Brown, S.; Head-Gordon, T. Intermediates and the folding of proteins L and G. Protein Sci. 2004, 13, 958-970.
20. Klyubin, I.; Walsh, D. M.; Cullen, W. K.; Fadeeva, J. V.; Anwyl, R.; Selkoe, D. J.; Rowan, M. J. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo. Eur. J. Neurosci. 2004, 19, 2839-2846.
21. Dolphin, G. T.; Dumy, P.; Garcia, J. Control of amyloid beta-peptide protofibril formation by a designed template assembly. Angew. Chem., Int. Ed. 2006, 45, 2699-2702.
22. Ferrone, F. Analysis of protein aggregation kinetics. Methods Enzymol. 1999, 309, 256-274.
23. Petkova, A. T.; Yau, W. M.; Tycko, R. Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry 2006, 45, 498-512.
24. Petkova, A. T.; Ishii, Y.; Balbach, J. J.; Antzutkin, O. N.; Leapman, R. D.; et al. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16742-16747.
25. Luhrs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Döbeli, H.; Schubert, D.; Riek, R. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17342-17347.
26. Fawzi, N. L.; Okabe, Y.; Yap, E. H.; Head-Gordon, T. Determining the critical nucleus and mechanism of fibril elongation of the Alzheimer's Aβ(1-40) peptide. J. Mol. Biol. 2007, 365, 535-550.
27. Buchete, N. V.; Tycko, R.; Hummer, G. Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments. J. Mol. Biol. 2005, 353, 804-821.
28. Buchete, N. V.; Hummer, G. Exploring the structural stability and the mechanism of dissociation of Alzheimer's amyloid fibrils. Biophys. J. 2007, 194A.
29. Petkova, A. T.; Leapman, R. D.; Guo, Z. H.; Yau, W. M.; Mattson, M. P.; Tycko, R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 2005, 307, 262-265.
30. Paravastu, A. K.; Petkova, A. T.; Tycko, R. Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide. Biophys. J. 2006, 90, 4618-4629.
31. Sawaya, M. R.; Sambashivan, S.; Nelson, R.; Ivanova, M. I.; Sievers, S. A.; Apostol, M. I.; Thompson, M. J.; Balbirnie, M.; Wiltzius, J. J. W.; McFarlane, H. T.; Madsen, A. Á.; Riekel, C.; Eisenberg, D. Atomic structures of amyloid cross-β spines reveal varied steric zippers. Nature 2007, 447, 453-457.
32. Ban, T.; Yamaguchi, K.; Goto, Y. Direct observation of amyloid fibril growth, propagation, and adaptation. Acc. Chem. Res. 2006, 39, 663-670.
33. Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300, 486-489.
34. Huet, A.; Derreumaux, P. Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations. Biophys. J. 2006, 91, 3829-3840.
35. Nilsberth, C.; Westlind-Danielsson, A.; Eckman, C. B.; Condron, M. M.; Axelman, K.; Forsell, C.; Stenh, C.; Luthman, J.; Teplow, D. B.; Younkin, S. G.; Naslund, J.; Lannfelt, L. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat. Neurosci. 2001, 4, 887-893.
36. Levy, E.; Carman, M. D.; Fernandez-Madrid, I. J.; Power, M. D.; Lieberburg, I.; van Duinen, S. G.; Bots, G. T.; Luyendijk, W.; Frangione, B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248, 1124-1126.
37. Fawzi, N. L.; Kohlstedt, K. L.; Okabe, Y.; Head-Gordon, T. Protofibril assemblies of the Arctic, Dutch and Flemish mutants of the Alzheimer's A{beta}1-40 peptide. Biophys. J. 2008, 94, 2007-2016.
38. Cheon, M.; Chang, I.; Mohanty, S.; Luheshi, L. M.; Dobson, C. M.; Vendruscolo, M.; Favrin, G. Structural reorganization and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comp. Biol. 2007, 3, 1727-1738.
39. Byeon, I. J. L.; Louis, J. M.; Gronenborn, A. M. A protein contortionist: Core mutations of GBI that induce dimerization and domain swapping. J. Mol. Biol. 2003, 334, 605-605.
40. Ramirez-Alvarado, M.; Cocco, M. J.; Regan, L. Mutations in the B1-domain of protein G that delay the onset of amyloid fibril formation in vitro. Protein Sci. 2003, 12, 567-576.
41. Grant, M. A.; Lazo, N. D.; Lomakin, A.; Condron, M. M.; Arai, H.; Yamin, G.; Rigby, A. C.; Teplow, D. B. Familial Alzhemier's disease mutations alter the stability of the amyloid-beta-protein monomer folding nucleus. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 16522-16527.
42. 21-30 peptide from the interplay of NMR experiments and molecular simulations. J. Am. Chem. Soc. 2008, 130, 6145-6158.
43. Sgourakis, N. G.; Yan, Y. L.; McCallum, S. A.; Wang, C. Y.; Garcia, A. E. The Alzheimer's peptides Abeta40,42 adopt distinct conformations in water: A combined MD/NMR study. J. Mol. Biol. 2007, 368, 1448-1457.
44. Cheng, I. H.; Scearce-Levie, K.; Legleiter, J.; Palop, J. J.; Gerstein, H.; Bien-Ly, N.; Puoliväli, J.; Lesné, S.; Ashe, K. H.; Muchowski, P. J.; Mucke, L. Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 2007, 282, 23818-23828.
45. Stern, E. A.; Bacskai, B. J.; Hickey, G. A.; Attenello, F. J.; Lombardo, J. A.; Hyman, B. T. Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques. J. Neurosci. 2004, 24, 4535-4540.
46. Zhang-Nunes, S. X.; Maat-Schieman, M. L. C.; van Duinen, S. G.; Roos, R. A. C.; Frosch, M. P.; Greenberg, S. M. The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol. 2006, 16, 30-39.
47. Kakio, A.; Nishimoto, S.; Yanagisawa, K.; Kozutsumi, Y.; Matsuzaki, K. Interactions of amyloid-β protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer-amyloid. Biochemistry 2002, 41, 7385-7390.